Moving Research from Bench to Bedside to Community

There Is Still More to Do

Published in: Journal of clinical oncology, v. 26, no. 4, Feb. 1, 2008, p. 523-526

Posted on RAND.org on December 31, 2007

by Katherine L. Kahn

Read More

Access further information on this document at jco.ascopubs.org

This article was published outside of RAND. The full text of the article can be found at the link above.

Findings illustrate that women with breast cancer are not receiving evidence-based care recommended by their physicians. Although tamoxifen or anastrozole therapy can be recommended for fewer than 5 years when used in conjunction with another agent, these investigators evaluated rates of adherence to prescribed medication, not a change in the physician's prescription. The influence on outcomes of the many possible patterns of lack of compliance with recommended treatment is not known. The extent to which expected outcomes would be hampered by patients using the drug intermittently or by cutting the daily, weekly, or monthly dose is not known.

This report is part of the RAND Corporation External publication series. Many RAND studies are published in peer-reviewed scholarly journals, as chapters in commercial books, or as documents published by other organizations.

The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.